david pejoski
Adoram Therapeutics SA
Geneva, Switzerland
Review Editor
Vaccines and Molecular Therapeutics
Adoram Therapeutics SA
Geneva, Switzerland
Review Editor
Vaccines and Molecular Therapeutics
Merck (Germany)
Darmstadt, Germany
Review Editor
Vaccines and Molecular Therapeutics
IRCCS Carlo Besta Neurological Institute Foundation
Milan, Italy
Review Editor
Vaccines and Molecular Therapeutics
UMR5075 Institut de Biologie Structurale (IBS)
Grenoble, France
Review Editor
Vaccines and Molecular Therapeutics
Northwestern University
Evanston, United States
Review Editor
Vaccines and Molecular Therapeutics
National Center for Biotechnology, Spanish National Research Council (CSIC)
Madrid, Spain
Review Editor
Vaccines and Molecular Therapeutics
University of Milano-Bicocca
Milan, Italy
Review Editor
Vaccines and Molecular Therapeutics
University of Regensburg
Regensburg, Germany
Review Editor
Vaccines and Molecular Therapeutics
CureVac AG
Tuebingen, Germany
Review Editor
Vaccines and Molecular Therapeutics
Institute for Research in Biomedicine (IRB)
Bellinzona, Switzerland
Review Editor
Vaccines and Molecular Therapeutics
Walter Reed Army Institute of Research
Silver Spring, United States
Review Editor
Vaccines and Molecular Therapeutics
School of Medicine, Duke University
Durham, United States
Review Editor
Vaccines and Molecular Therapeutics
Centre for Genomic Regulation (CRG)
Barcelona, Spain
Review Editor
Vaccines and Molecular Therapeutics
Utrecht University
Utrecht, Netherlands
Review Editor
Vaccines and Molecular Therapeutics
Institute for Immunology, University Medical Centre, Johannes Gutenberg University Mainz
Mainz, Germany
Review Editor
Vaccines and Molecular Therapeutics
Centre Hospitalier Regional et Universitaire de Lille
Lille, France
Review Editor
Vaccines and Molecular Therapeutics